While ART initiation at high CD4 counts is expected to reduce incident TB rates[16, 20, 35], there is need to strengthen TB screening algorithms and combine with biomarkers to ensure that patients at increased risk of TB are identified and appropriate interventions instituted. This evidence concerns the gene CD4 and tuberculosis.